2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
TAYSHA GENE THER (TSHA)
NASDAQ
$4.22+$0.12 (+2.93%)
Price as of Nov 13, 2026 5:34 PM EST- $1.4BMarket Cap
- -0.73%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$4.22+$0.12 (+2.93%)
TSHA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.10 | ||
Change | -$0.11 (-2.61%) | ||
Open | $4.24 | ||
High | $4.33 | ||
Low | $3.98 | ||
Previous Close | $4.21 | ||
Volume | 2,474,566 | ||
30-Day Average Volume | 3,519,962 | ||
1-Week Change | -5.31% | ||
1-Month Change | 14.53% | ||
1-Year Change | -0.73% | ||
3-Year Change | 208.27% | ||
5-Year Change | -72.56% | ||
Fundamentals | |||
Shares Outstanding | 325.8M | ||
Total Assets | $435.0M | ||
Market Cap | $1.4B | ||
Enterprise Value | $996.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$39.1M | ||
Free Cash Flow | -$33.4M | ||
EBIT | -$39.1M | ||
EBITDA | -$38.9M | ||
Net Working Capital | $403.1M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -41 | ||
PEG | -2 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue